Related by context. All words. (Click for frequent words.) 83 DAVANAT R 72 Davanat 67 Civacir 66 Onconase 66 MGCD# [001] 65 Virulizin R 65 polysaccharide polymer 65 PLK1 SNALP 65 ASONEP 64 atacicept 64 Archexin 64 Bendamustine 64 CoFactor 64 IMA# 64 DPX Survivac 63 Panzem R NCD 63 Octreotide 63 YONDELIS 63 PHX# 63 PXD# 63 DAVANAT 63 L BLP# 63 Loramyc R 63 Icatibant 63 Allovectin 7 R 63 KNS # 63 MEK inhibitor 63 Argatroban 62 MyVax R 62 NEBIDO 62 JAK inhibitor 62 methylnaltrexone 62 Panzem R 62 Cloretazine ® 62 eniluracil 62 Azedra 62 HuMax CD4 62 HGS ETR1 62 elotuzumab 62 oral prodrug 62 Indaflex TM 62 anticancer compound 62 TREANDA 62 Virulizin 62 pitavastatin 62 amrubicin 62 Aflibercept 62 Amrubicin 62 Xanafide 62 ridaforolimus 62 Campath ® 62 targets Galectin receptors 62 anticancer agent 62 prGCD 62 Urokinase 61 IMC #B 61 PDE4 inhibitor 61 ATL# [001] 61 Onalta 61 therapeutic monoclonal antibodies 61 TOCOSOL Paclitaxel 61 Soliris TM eculizumab 61 OvaRex R 61 EndoTAG TM -1 61 targeted radiotherapeutic 61 epothilone 61 Velcade bortezomib 61 Interferon alpha 61 Amigal 61 FOLOTYN ® 61 OvaRex ® MAb 61 tafamidis 61 OncoVEX GM CSF 61 ONCONASE 61 HuMax CD# 61 Cethrin 61 Gemzar ® 61 PrevOnco ™ 61 MBP# [001] 61 successfully commercialize Iluvien 61 therapeutic monoclonal antibody 61 DXL# 61 Angiocept 61 candidate deforolimus 61 #D#C# 61 tezampanel 61 enzastaurin 61 PCK# 61 TYZEKA 61 NeuroSTAT ® 61 Bezielle 61 XYOTAX TM 61 TRO# 61 VALSTAR 61 liposomal formulation 60 CINOD 60 rxRNA 60 ganetespib 60 Asentar 60 Oral lyn 60 cancer immunotherapies 60 AQ4N 60 IND submission 60 ONCONASE R 60 NexACT ® 60 Evoltra 60 Onco TCS 60 KRN# 60 paclitaxel Taxol ® 60 reslizumab 60 Factor VIIa 60 MAXY G# 60 Phase Ib study 60 MOZOBIL 60 IAP inhibitors 60 Phase #b/#a clinical 60 molecular imaging radiopharmaceutical 60 mitogen activated ERK kinase 60 otelixizumab 60 SNT MC# 60 AAG geldanamycin analog 60 Omacetaxine 60 PNT# 60 GAP #B# 60 BEMA Fentanyl 60 Evoltra TM 60 Alzhemed TM 60 YONDELIS R 60 R#/MEM # 60 Zingo TM 60 antisense drug 60 vosaroxin 60 ALN VSP 60 picoplatin 60 Orapred ODT 60 CTCE 60 OMP #M# 60 IRX 2 60 Chemophase 60 Pertuzumab 60 BNC# 60 QRxPharma 60 Guanilib 60 Surfaxin LS 60 Telatinib 60 DermaVir Patch 60 candidate epratuzumab 60 HCV protease inhibitor 60 INCB# [001] 60 IMC A# 60 ARRY # 60 deforolimus 60 Ceflatonin 60 OncoVEX 60 Chemokine Therapeutics 60 HuMax TAC 60 Relivar 60 RDEA# 60 entinostat 60 drug ISA# 60 Myocet 60 Personalized Immunotherapy 60 Neurodex 60 Talabostat 60 ZADAXIN ® 60 ixabepilone 60 BAY #-# 60 Alocrest 60 OHR/AVR# 60 Aviptadil 60 Urocidin TM 60 ApoB SNALP 60 NexACT 59 Synavive 59 Marqibo TM 59 Cellegesic 59 Amplimexon 59 ATryn R 59 Phase IIb clinical trials 59 Jevtana 59 Phase #b/#a 59 XmAb# 59 mertansine 59 Annamycin 59 ISTODAX 59 Troxatyl 59 Vaccinex 59 motexafin gadolinium Injection 59 oral ridaforolimus 59 pralatrexate 59 torezolid phosphate 59 Exherin TM 59 Fortical R 59 ONTAK 59 alvimopan 59 Allovectin 7 59 Pimavanserin 59 Spiegelmer ® 59 HepaGam B 59 AMD# [003] 59 Urocidin 59 CEQ# 59 Ixempra 59 Cardio Vascu Grow 59 Hematide TM 59 sumatriptan DosePro 59 AEG# 59 Nebido 59 histamine dihydrochloride 59 IMP# 59 NEUMUNE 59 OncoGel 59 PI3K/Akt pathway inhibitor 59 Eniluracil 59 subcutaneous formulation 59 Seliciclib 59 ALN PCS 59 voreloxin 59 ZEVALIN ® 59 forodesine 59 MAXY VII 59 Vilazodone 59 Multikine 59 Cloretazine 59 Anthim 59 INT# [002] 59 investigational therapies 59 Pivotal Phase III 59 LIVALO 59 BEXXAR 59 tamibarotene 59 LEP ETU 59 IL# PE#QQR 59 GLPG# 59 Erbitux cetuximab 59 lorvotuzumab mertansine 59 RIGScan CR 59 thymalfasin 59 tolevamer 59 docetaxel Taxotere ® 59 Orphan Drug designation 59 vorinostat 59 Excellagen 59 obatoclax 59 PEG SN# 59 bardoxolone 59 THR beta agonist 59 incyclinide 59 dasatinib Sprycel 59 LHRH antagonist 59 Diamyd ® 59 CINTREDEKIN BESUDOTOX 59 BioNumerik 59 ONCASPAR 59 Multiferon 59 liprotamase 59 Anturol ® 59 Tezampanel 59 Serdaxin 59 Raptiva ® 59 Panzem 59 Celator 59 Oncaspar 59 Intravenous CP 59 drug GAP #B# 59 Insegia 59 Nexavar ® 59 custirsen 59 Cetrorelix 59 Sym# 59 UPLYSO 59 tanespimycin 59 Genasense ® oblimersen 59 ZADAXIN 59 Technosphere Insulin 59 MORAb 59 siRNA therapeutics 59 oral antiviral 59 LEVADEX ™ 59 ZK EPO 59 Flutiform TM 59 investigational humanized monoclonal antibody 59 MEK inhibitors 59 AZILECT ® 59 epothilones 59 Fibrillex TM 58 Allovectin 7 ® 58 Aganocide 58 Anavex #-# 58 ZOLINZA 58 palonosetron 58 docetaxel Taxotere R 58 Clofarabine 58 orally bioavailable 58 sodium Injection 58 Curaxin 58 HyACT 58 PNP inhibitor 58 defensin mimetic antibiotic 58 HCV polymerase inhibitor 58 Traficet EN 58 Combidex 58 EFAPROXYN 58 clofarabine 58 HGS ETR2 58 interferon gamma 1b 58 Nascobal 58 Azedra TM 58 DOS# 58 PRT# 58 GGF2 58 Excellarate 58 Nanobody 58 Allovectin 7 r 58 Solazed 58 vidofludimus 58 ARIKACE ™ 58 Curaxin CBLC# 58 trabectedin 58 Bortezomib 58 Nexavar sorafenib tablets 58 sorafenib tablets 58 BZL# 58 PDX pralatrexate 58 M Enoxaparin 58 Bioral 58 Omapro 58 LEUKINE 58 CCX# 58 Phase 2a clinical trials 58 sargramostim 58 Perifosine 58 Zavesca r 58 Zerenex 58 PrevOnco 58 OPAXIO 58 alvespimycin 58 Plenaxis TM 58 OLEPTRO 58 G#DT 58 Tamibarotene 58 BioVant 58 Fodosine 58 phase IIb clinical 58 phase IIa clinical 58 MOR# 58 mitiglinide 58 AP# [003] 58 HuLuc# 58 Indaflex 58 GP Pharm 58 PROCAPS 58 Vandetanib 58 Arimoclomol 58 IV Busulfex 58 Alvesco R 58 ATryn ® 58 teduglutide 58 Marqibo 58 SEBIVO 58 HDAC Inhibitor 58 Tesmilifene 58 nanopharmaceutical 58 Leukine 58 #ME# 58 Oracea TM 58 Biologics License Application 58 Proxinium TM 58 huC# DM4 58 PSN# [001] 58 Orphan Drug Designation 58 FoldRx 58 ADVEXIN 58 Tolerx 58 Mipomersen 58 Trofex 58 Tarvacin TM 58 Zolinza 58 BLA filing 58 BEMA Granisetron 58 oral taxane 58 synthetic retinoid 58 Symadex 58 Ceflatonin ® 58 satraplatin 58 romidepsin 58 Shigamabs R 58 valtorcitabine 58 immatics 58 PROCHYMAL 58 CRD5 58 PANVAC VF 58 SRT# [003] 58 Nipent R 58 Phenoptin 58 TG# [003] 58 AZILECT R 58 HGS# 58 pradefovir 58 Granulocyte Colony Stimulating Factor 58 NXL# 58 BLP# Liposome Vaccine 58 HIV protease inhibitor 58 Neuradiab 58 ENTEREG ® 58 Maribavir 58 PSMA ADC 58 Ceflatonin R 58 daclizumab 58 BEMA TM Fentanyl 58 MYDICAR ® 58 Vivecon 58 Advexin 58 Pennsaid R 58 acetonide FA 58 immunotherapeutic 58 Viprinex 58 silodosin 58 Zenpep 58 ALN RSV# 58 Tesetaxel 58 Irinotecan 58 Androxal TM 58 Daclizumab 58 Cx# [002] 58 volociximab 58 Biologic License Application BLA 58 CD# antibody [001] 58 TOCOSOL 58 GVAX ® 58 fipamezole 58 GRNVAC1 58 acyclovir Lauriad R 58 Virulizin ® 58 Qutenza TM 58 vascular disrupting agents 58 axitinib 58 ART# 58 HQK 58 Nexavar sorafenib 58 Sucanon ® 58 PhosLo 58 Ampligen r 58 Cerimon 58 XL# XL# 58 specific lectin receptors 58 orally administered inhibitor 58 angiogenesis inhibitor 58 Ixabepilone 58 ICA # 58 Reolysin 58 Dalbavancin 58 tranilast 58 Kepivance 58 dalbavancin 58 Plenaxis R 58 Cethromycin 58 INCB# [002] 58 omacetaxine 58 voclosporin 58 Soliris eculizumab 58 Pemetrexed 58 Protexia ® 58 Bellicum 57 TOCOSOL R 57 EP #R 57 Sanvar R 57 DCCR 57 Loramyc ® 57 OXi# 57 depsipeptide 57 BiovaxID TM 57 ularitide 57 Eribulin 57 BENLYSTA ® 57 topical ophthalmic 57 Mozobil 57 Onrigin 57 Glufast 57 ELND# 57 buccal insulin spray 57 CIMZIA TM 57 Aloxi R 57 Phase III Clinical Trial 57 CBLC# 57 Neovastat 57 ATL# [002] 57 MAGE A3 ASCI 57 Maxy G# 57 faropenem 57 Sylvie Gregoire President 57 Polymer Microspheres 57 anti EGFR antibody 57 Æterna Zentaris 57 Cloretazine R VNP#M 57 topically applied SEPA 57 intranasal formulation 57 PREOS 57 HepeX B TM 57 compound ISA# 57 MAA submission 57 Adenosine Therapeutics 57 lixivaptan 57 DepoDur 57 Lumacan 57 Plicera 57 orBec 57 Initiates Enrollment 57 Nektar PEGylation technology 57 Azilect ® 57 immune modulatory 57 Fentanyl Taifun 57 AVN# [001] 57 VitiGam 57 TRANSDUR Sufentanil 57 ospemifene 57 2 methoxyestradiol 57 Enobia 57 NovaDel 57 Ophthotech 57 FACTIVE R gemifloxacin 57 Rasagiline 57 Strativa 57 bortezomib Velcade 57 EOquin 57 Xcytrin R 57 Emezine 57 BLA submission 57 Preotact 57 rhThrombin 57 HspE7 57 Fleximer 57 Aurexis 57 Anidulafungin 57 DORIBAX 57 metaglidasen 57 BrachySil 57 THALOMID 57 SinuNase 57 Targretin capsules 57 ARIKACE 57 Corlux 57 Rebif ® 57 PF # [002] 57 HCV protease inhibitors 57 Ketotransdel 57 mapatumumab 57 registrational 57 RGB # 57 Phase IIB 57 OMAPRO 57 Targeted Chemotherapy 57 Initiate Clinical Trial 57 VAPRISOL 57 talabostat 57 CB2 selective receptor agonist 57 Onsolis 57 Adventrx 57 histone deacetylase inhibitor 57 Diamyd R 57 Onalta ™ 57 Genasense ® 57 TOCOSOL Camptothecin 57 Bavituximab 57 Genasense R oblimersen 57 Solasia 57 CIP TRAMADOL ER 57 RELISTOR ® 57 Dual Opioid 57 Valortim 57 preclinically 57 BrachySil TM 57 Chrysalin 57 histone deacetylase HDAC inhibitor 57 rThrombin 57 PREOS R 57 talactoferrin 57 RECOTHROM R 57 TELINTRA 57 SNS# T 57 sapacitabine 57 ABILIFY ® 57 Orphan Status 57 ALN TTR# 57 Kahalalide F 57 Phase 2a trial 57 Pradefovir 57 Memryte 57 Aurora Kinase 57 PRTX 57 Locteron ® 57 Hycamtin 57 Generx ™ 57 taliglucerase alfa 57 Dapagliflozin 57 TRISENOX 57 pharmacological chaperone 57 FOR FURTHER INFORMATION ABOUT 57 EGRIFTA TM 57 REMICADE infliximab 57 ANYARA 57 RhuDex ® 57 BENLYSTA 57 Kamada AAT 57 SPRYCEL ® 57 Canvaxin 57 nucleoside analog 57 CCR5 antagonist 57 PLX# 57 HepeX B 57 glucagon receptor 57 oral anticancer 57 TBC# 57 pomalidomide 57 Iluvien ® 57 seliciclib CYC# 57 BiTE 57 PEG Interferon lambda 57 Scancell 57 Mepact 57 CR# vcMMAE 57 sunitinib malate 57 Targretin 57 Cethrin R 57 Zensana 57 ThermoDox R 57 phase IIb trial 57 Dacogen injection 57 candidate Zenvia 57 topical NSAID 57 CRMD# 57 tezampanel NGX# 57 HepaGam B R 57 EOquin TM 57 Zensana TM 57 regorafenib 57 rilonacept 57 Thallion 57 ONSOLIS 57 Intravenous Human 57 erlotinib Tarceva ® 57 Clavis Pharma 57 Aurora kinase inhibitor 57 proteasome inhibitor 57 Relypsa 57 Stimuvax R 57 Injectable Suspension 57 SYCREST 57 antibody MAb 57 Stedivaze 57 pegfilgrastim 57 Bioral Amphotericin B 57 Aegerion 57 IgG1 monoclonal antibody 57 trastuzumab Herceptin R 57 Phase 2b Clinical Trial 57 Anturol TM 57 Aplidin 57 Tarmogen 57 cinacalcet HCl 57 rNAPc2 57 Tyrima 57 Filgrastim 57 DPP4 inhibitor 57 tesmilifene 57 GALNS 57 panitumumab Vectibix 57 hyperimmune products 57 Velac 57 LymphoStat B TM 57 mifamurtide 57 vinorelbine emulsion 57 PROMACTA 57 apaziquone 57 EZN 57 Oasmia 57 Belinostat 56 rasagiline tablets 56 NanoCrystal technology 56 Muraglitazar 56 Apricus Bio 56 Glassia 56 Zalbin 56 beta 1a 56 Keppra ® XR 56 HDL Mimetic Peptide 56 OMP #R# 56 novel peptide 56 H#N# VLP vaccine 56 Abraxane 56 DR Cysteamine 56 Lovaza TM 56 Pazopanib 56 siRNA therapeutic 56 Angiolix 56 TACI Ig 56 TLR9 agonists 56 cannabinor 56 LUCASSIN 56 Cerashield 56 RAPTIVA 56 Thelin TM 56 NDA Submission 56 StemEx R 56 Kevetrin ™ 56 novel peptides 56 Lisofylline LSF 56 investigational pan BCR 56 Varespladib 56 targeting CD# 56 Campath alemtuzumab 56 ruxolitinib 56 orphan designation 56 Nanobody R 56 MEPACT 56 JAK1 56 Recombinant Human 56 Hsp# Inhibitor 56 Ontak 56 #I TM# 56 virus HCV protease inhibitor 56 Emselex 56 PROCAPS SA 56 oral picoplatin 56 CIMZIA ™ 56 Removab 56 tivozanib 56 L DOS# 56 Presents Preclinical Data 56 TOLAMBA 56 VitiGam TM 56 Retacrit 56 Chemokine 56 CYC# 56 ZEFTERA TM Zevtera TM 56 immune stimulatory 56 ELACYT 56 ZFP Therapeutics 56 rALLy trial 56 BRAF inhibitor 56 BCR ABL inhibitor 56 MoxDuo IR 56 tramiprosate 56 Oncolys 56 GLP toxicology studies 56 Taxotere docetaxel 56 tiapamil 56 Phase Ib 56 valopicitabine 56 Neulasta ® 56 iSONEP 56 Multiferon R 56 ADVEXIN p# therapy 56 omacetaxine mepesuccinate 56 candidates bavituximab 56 Sphingomab 56 SEASONALE R 56 inhaled AAT 56 AMRIX 56 relapsed leukemia 56 Zelrix 56 TKM PLK1 56 Fibrillex 56 Portola Pharmaceuticals 56 ALTROPANE R 56 Expression Genetics 56 ofatumumab 56 PORxin TM 56 GRN#L 56 ProMune 56 IMiDs 56 Factor Xa inhibitor 56 fidaxomicin 56 Receives Orphan Drug Designation 56 HEPLISAV ™ 56 Dextofisopam 56 recombinant biopharmaceutical 56 confirmatory Phase III 56 Cloretazine R 56 NPC 1C 56 lumiliximab 56 Protexia R 56 Fx #A 56 PROVENGE sipuleucel T 56 COLAZAL R 56 MNTX 56 Actimmune ® 56 AzaSite Plus 56 vascular disrupting agent 56 lintuzumab 56 Tasimelteon 56 Generx TM 56 Bayer Onyx 56 Cinryze ™ 56 indibulin 56 Zegerid OTC 56 APF# 56 oncolytic virus 56 Alnara 56 Debio 56 Cand5 56 Tarceva TM 56 Adnectin 56 Aegerion Pharmaceuticals 56 Abstral 56 HIV integrase inhibitor 56 StaphVAX R 56 Saforis 56 Elagolix 56 G CSF 56 registrational studies 56 Omthera 56 Unit Dose Budesonide 56 ocular formulation 56 Toraymyxin TM 56 relapsed multiple myeloma 56 Sinobiopharma 56 Octreolin 56 Quinamed 56 eTag assays 56 Catena ® 56 selective immunoproteasome inhibitor 56 HepaSphere 56 sodium glucose transporter 56 Mpex 56 AKT inhibitor 56 Ophena 56 GW# [003] 56 IIa trial 56 ENMD # 56 PharmFilm ® 56 selective androgen receptor modulator 56 Initiates Phase II 56 4SC AG 56 DCVax R 56 CCR9 antagonist 56 RNAi therapeutic 56 TELCYTA 56 FluCide 56 targeted antifolate 56 multi kinase inhibitor 56 VentiRx 56 telomerase therapeutic 56 trastuzumab DM1 T DM1 56 Trastuzumab DM1 56 Junovan TM 56 Syncria 56 Zebinix R 56 immunotherapeutic vaccine 56 favorable pharmacokinetic profile 56 Gleevec imatinib mesylate 56 IND Investigational New 56 Initiates Phase III 56 Zirgan 56 epigenetic therapies 56 DP b# 56 dasatinib Sprycel ® 56 SYGNIS 56 Bicifadine 56 personalized immunotherapy 56 Proquin XR 56 Simulect 56 RSR# 56 docetaxel Taxotere 56 refractory chronic lymphocytic 56 IoGen 56 Evoltra ® 56 phenoxodiol 56 non nucleoside HCV 56 Squalamine 56 Solazed TM 56 Vion Pharmaceuticals 56 Arcalyst 56 Reports Preclinical Data 56 PEGylated Fab fragment 56 panitumumab 56 Prednisporin TM 56 blood clot dissolver 56 glucokinase activator 56 Anticalin 56 leading oral taxane 56 Golimumab 56 Files Investigational 56 Arranon 56 TRANSDUR Bupivacaine 56 GENERIC SILDENAFIL SOFT Generic 56 JAK Inhibitor 56 ProLindac TM 56 FOLOTYN 56 Generex Oral lyn 56 lapatinib Tykerb 56 filgrastim 56 PEGPH# 56 ulimorelin 56 IND enabling 56 metastatic hormone refractory 56 nalbuphine ER 56 thalidomide Thalomid 56 small molecule Hedgehog 56 HCV protease 56 Fanapt TM 56 IRESSA 56 fusion inhibitor 56 Temsirolimus 56 ORTHOCON 56 elvucitabine 56 Bronchitol 56 Junovan 56 R#/MEM 56 midstage clinical 56 TIMERx 56 miconazole Lauriad ® 56 Prodarsan ® 56 RenaZorb TM 56 Abiraterone acetate 56 octreotide implant 56 MKC# MKC# PP 56 novel histone deacetylase 56 IV APAP 56 Generex Oral lyn TM 56 CVac 56 NEUGENE 56 Captisol enabled 56 Tostrex 56 Q#IR 56 Saxagliptin 56 IAP inhibitor 56 intravenous formulations 56 Avastin bevacizumab 56 ANAVEX #-# [001] 56 long acting muscarinic 56 Mylotarg 56 Emend 56 EVIZON TM 56 Elesclomol 56 Ampligen ® 56 lomitapide 56 HuMax EGFr 56 Perforomist ™ Inhalation Solution 56 Vivaglobin 56 EpiCept NP 1 56 TEMODAL 56 CORT # 56 Exelixis compounds 56 Cannabinor 56 UVIDEM 56 HepDirect 56 Lenocta 56 ISIS # 56 eltrombopag 56 Aganocide ® 56 SUTENT ® 56 Zemiva TM 56 Cleviprex TM clevidipine 56 CA4P 56 VEGF Trap 56 ProSavin 56 HSP# inhibitor 56 Meets Primary Endpoint 56 Zorbtive TM 56 ALN HTT 56 MGd 56 Vidaza R 56 renin inhibitor 56 intravenous acetaminophen 56 Elotuzumab 56 ILUVIEN ® 56 Metaphore 56 RiVax 56 erlotinib Tarceva 56 Tridural TM 56 fenofibric acid 56 MONOVISC 56 BioDelivery Sciences 56 PolyActive ® 55 lucinactant 55 Gelclair 55 preclinical studies 55 LibiGel ® 55 subsidiaries visit http:/www.apricusbio.com 55 EGS# 55 Oracea 55 vinorelbine tartrate 55 InvaGen 55 vinca alkaloid 55 MT# MEDI 55 TORISEL 55 ZYFLO CR 55 sorafenib Nexavar 55 crofelemer 55 Preclinical studies suggest 55 GenWay Biotech 55 PROSTVAC TM 55 tramiprosate ALZHEMED TM 55 LEVADEX TM 55 Orathecin 55 NerPharMa 55 small molecule defensin 55 Zelapar